Golimumab Subcutaneous and Loteprednol and Tobramycin
Determining the interaction of Golimumab Subcutaneous and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Loteprednol and tobramycin ophthalmic
- Golimumab Subcutaneous-Loteprednol Etabonate
- Golimumab Subcutaneous-Loteprednol Eye Drops
- Golimumab Subcutaneous-Loteprednol Eye Drops 0.2%
- Golimumab Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Golimumab Subcutaneous-Loteprednol Eye Gel
- Loteprednol and Tobramycin-GoLYTELY
- Loteprednol and Tobramycin-Gonadorelin
- Loteprednol and Tobramycin-Gonadorelin Intravenous, Injection
- Loteprednol and Tobramycin-Gonadotropin, Chorionic
- Loteprednol and Tobramycin-Gonal-F
- Loteprednol and Tobramycin-Gonal-f RFF